GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pfizer Inc (XTER:PFE) » Definitions » Selling and Marketing Expense

Pfizer (XTER:PFE) Selling and Marketing Expense : €0 Mil (TTM As of Sep. 2024)


View and export this data going back to 1996. Start your Free Trial

What is Pfizer Selling and Marketing Expense?

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services. Pfizer's Selling and Marketing Expense for the three months ended in Sep. 2024 was €0 Mil. Its Selling and Marketing Expense for the trailing twelve months (TTM) ended in Sep. 2024 was €0 Mil.

Pfizer Selling and Marketing Expense Historical Data

The historical data trend for Pfizer's Selling and Marketing Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pfizer Selling and Marketing Expense Chart

Pfizer Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Selling and Marketing Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Pfizer Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Selling and Marketing Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Pfizer Selling and Marketing Expense Calculation

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services.

Selling and Marketing Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pfizer Selling and Marketing Expense Related Terms

Thank you for viewing the detailed overview of Pfizer's Selling and Marketing Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Pfizer Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pfizer Inc (XTER:PFE) » Definitions » Selling and Marketing Expense
Comparable Companies
AMGN BMY GILD MRK BIIB OGN AMRN SCLX MIRA ABBV LLY OCSE:NOVO B JNJ XSWX:ROG XSWX:NOVN LSE:AZN XPAR:SAN LSE:GSK TSE:4519 TSE:4568
Traded in Other Exchanges
PFE:USA PFE:Peru PFE:Mexico PFE_KZ:Kazakhstan 1PFE:Italy PFEd:UK PFEB:Germany PFE:Germany PFE:Germany PFE:Germany PFE:Canada PFIZ34:Brazil PFE:Bulgaria PFE:Austria PFE:Argentina
Address
66 Hudson Boulevard East, New York, NY, USA, 10001-2192
Website
https://www.pfizer.com
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.